Delivery Order SPE2DB24D9222-SPE2DB25FAZKB
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, effective August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,229.60 contract is for the supply of BOTOX 100 unit vials to support the recurring medical needs of military health facilities. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a single-award transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no...
- On August 13, 2025, the Defense Logistics Agency awarded a delivery order valued at $2,775.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 4, 2025, and carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $97,027.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,845.92 contract is for the supply of BOTOX 100 unit vials, with a period of performance through August 8, 2024. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999. The...
- SPE2DB24D9222Indefinite Delivery Contract
- SPE2DB24D9222-SPE2DB25FAZKBDelivery Order
The Defense Logistics Agency awarded a $67,919.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026, which authorizes the agency to procure a comprehensive portfolio of pharmaceutical products and medical supplies for Defense Department healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, consistently securing contracts for specialty medications and biologics including oncology treatments, vaccines, and other critical medical products. The company's role in supplying BOTOX to military health facilities reflects DLA's requirement for pharmaceutical products supporting medical operations across Department of Defense healthcare sites. With its 24-year history as a registered federal contractor and established expertise in distributing both branded and generic pharmaceuticals to government agencies, DMS Pharmaceutical Group continues to leverage its woman-owned small business status to compete effectively in federal procurement markets while maintaining a robust portfolio of delivery orders across multiple product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $67.9k | 8/19/25 |